Treatment guidelines recommend neoadjuvant or adjuvant therapies with surgery for patients with large primary tumors or clinical evidence of intrathoracic nodal spread.1,2 A recent joint IASLC–U.S. Food and Drug Administration […]
The absence of an OS benefit in more than 3 decades of clinical trials for extensive-stage SCLC (ES-SCLC) had become an all-too-familiar refrain among the introductions to numerous publications and […]
By Christian Rolfo, MD, PhD, MBA, Dr.hc. Over the past several years, three large randomized clinical trials demonstrated that low-dose computed tomography (LDCT) screening is a valuable method for lung […]
By Sandip Pravin Patel, MD, and Martin Edelman, MD Posted: August 21, 2020 Dr. Sandip Pravin Patel Dr. Martin Edelman […]
By Maria Antonia Velez, MD; Nanruoyi Zhou, BA; Brian Henick, MD; and Aaron Lisberg, MD Posted: August 21, 2020 Immune checkpoint inhibitors (CPIs) have revolutionized the treatment of metastatic NSCLC. […]
By Luis E. Raez, MD, FACP, FCCP Posted: August 21, 2020 Our current electronic medical records (EMR) are equipped with telehealth capability. Some of us have spent the last 2 […]
By Ross Soo, MB, BS, PhD, FRACP Posted: August 21, 2020 Dr. Ross Soo Impressive progress has been achieved in many aspects of lung cancer. Over the past […]
By Jennifer Byrne Posted: August 21, 2020 For nearly 2 decades, Bonnie Anderson has defied incredible odds in the face of mesothelioma, hairy cell leukemia, breast cancer, lung cancer, and […]
By Kara Nyberg, PhD Posted: August 21, 2020 A multitude of factors contribute to disparities in lung cancer care, including sex, race, education level, income, geographic region, and access to […]
By Mary Jo Fidler, MD Posted: August 21, 2020 At the American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program Plenary Session, an early look at data from the […]